Cargando…

Correction: Signally via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Miscellaneous
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034340/ https://www.ncbi.nlm.nih.gov/pubmed/32034032 http://dx.doi.org/10.1136/gutjnl-2015-310752corr1

Ejemplares similares

Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury
por: Arriazu, Elena, et al.
Publicado: (2017)

Key Fibrogenic Signaling
por: He, Weichun, et al.
Publicado: (2015)

Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis
por: Cao, Yunlei, et al.
Publicado: (2019)

Osteopontin deletion drives hematopoietic stem cell mobilization to the liver and increases hepatic iron contributing to alcoholic liver disease
por: Magdaleno, Fernando, et al.
Publicado: (2017)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

Correction: Fibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver
por: Baertschiger, Reto M., et al.
Publicado: (2009)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

The fibrogenic process and the unleashing of acute-on-chronic liver failure
por: López-Sánchez, Guillermo Nahúm, et al.
Publicado: (2020)

Astragali Radix Contributes to the Inhibition of Liver Fibrosis via High-Mobility Group Box 1-Mediated Inflammatory Signaling Pathway
por: Wen, Jianxia, et al.
Publicado: (2021)

Resident Fibroblast MKL1 Is Sufficient to Drive Pro-fibrogenic Response in Mice
por: Huang, Shan, et al.
Publicado: (2022)

Correction: Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell. A meta-analysis and functional study
Publicado: (2019)

Hexafluoroisopropanol decreases liver ischemia–reperfusion injury by downregulation of high mobility group box‐1 protein
por: Vintimilla Moscoso, Agustin, et al.
Publicado: (2022)

Osteopontin inhibits osteoarthritis progression via the OPN/CD44/PI3K signal axis
por: Liu, Qing, et al.
Publicado: (2020)

The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury
por: Gou, Xiaoyun, et al.
Publicado: (2020)

GIV/Girdin is a central hub for pro-fibrogenic signalling networks during liver fibrosis
por: Lopez-Sanchez, Inmaculada, et al.
Publicado: (2014)

Correction: Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018
Publicado: (2019)

The balance of powers: Redox regulation of fibrogenic pathways in kidney injury
por: Okamura, Daryl M., et al.
Publicado: (2015)

Identifying Fibrogenic Cells Following Salivary Gland Obstructive Injury
por: Altrieth, Amber L., et al.
Publicado: (2023)

Identifying fibrogenic cells following salivary gland obstructive injury
por: Altrieth, Amber L., et al.
Publicado: (2023)

Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion
por: Stearns‐Reider, Kristen M., et al.
Publicado: (2017)

Liver kinase B1 inhibits smooth muscle calcification via high mobility group box 1
por: Zhang, Tianran, et al.
Publicado: (2020)

Inflammation Writes the Fibrogenic Code
por: Friedersdorf, Matthew, et al.
Publicado: (2021)

The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
por: Albertsson, Anna-Maj, et al.
Publicado: (2014)

Correction: Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment
Publicado: (2017)

Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy
por: Douglass, Angela, et al.
Publicado: (2008)

Fibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver
por: Baertschiger, Reto M., et al.
Publicado: (2009)

Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial Lipopolysaccharide in the Liver
por: Gandhi, Chandrashekhar R.
Publicado: (2020)

Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
por: Subramanian, Pallavi, et al.
Publicado: (2022)

Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2011)

Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury
por: Mikus, Maria, et al.
Publicado: (2016)

Correction: Unintentional injuries in Mexico, 1990–2017: findings from the Global Burden of Disease Study 2017
Publicado: (2020)

Correction: Morbidity and mortality from road injuries: results from the global Burden of Disease Study 2017
Publicado: (2020)

High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy
por: Thakur, Vikram, et al.
Publicado: (2020)

Role of Osteopontin in Liver Diseases
por: Wen, Yankai, et al.
Publicado: (2016)

Correction: Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism
Publicado: (2019)

Correction: Pivotal role of High-Mobility Group Box 2 in ovarian folliculogenesis and fertility
por: Shirouzu, Shinichiro, et al.
Publicado: (2023)

Targeting danger molecules in tendinopathy: the HMGB1/TLR4 axis
por: Akbar, Moeed, et al.
Publicado: (2017)

Correction: Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017
Publicado: (2020)

Correction: Emotion regulation group therapy for deliberate self-harm: a multi-site evaluation in routine care using an uncontrolled open trial design
Publicado: (2017)

TGF-β in developmental and fibrogenic EMTs
por: Lee, Jun Ho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ahn25rbfj89e131crg83ss0vuu